APA (7th ed.) Citation

He, B. (2021). Blockade of CD95/CD95L death signaling enhances CAR T cell persistence and antitumor efficacy. https://doi.org/10.11588/heidok.00030527

Chicago Style (17th ed.) Citation

He, Bailin. Blockade of CD95/CD95L Death Signaling Enhances CAR T Cell Persistence and Antitumor Efficacy. Heidelberg, 2021. https://doi.org/10.11588/heidok.00030527.

MLA (9th ed.) Citation

He, Bailin. Blockade of CD95/CD95L Death Signaling Enhances CAR T Cell Persistence and Antitumor Efficacy. 2021. https://doi.org/10.11588/heidok.00030527.